UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemia

The Journal of clinical investigation, 2000-09, Vol.106 (5), p.705-714

2000

Volltextzugriff (PDF)

Expansion, persistence, and efficacy of donor memory-like NK cells infused for posttransplant relapse

The Journal of clinical investigation, 2022-06, Vol.132 (11)

2022

Volltextzugriff (PDF)

The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation

Blood, 2001-12, Vol.98 (12), p.3192-3204

2001

Volltextzugriff (PDF)

Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease

Blood, 2005-10, Vol.106 (8), p.2903-2911

2005

Volltextzugriff (PDF)

Biologic Activity of Cytotoxic T Lymphocyte-Associated Antigen 4 Antibody Blockade in Previously Vaccinated Metastatic Melanoma and Ovarian Carcinoma Patients

Proceedings of the National Academy of Sciences - PNAS, 2003-04, Vol.100 (8), p.4712-4717

2003

Volltextzugriff (PDF)

Immune modulation and chronic graft-versus-host disease

Bone marrow transplantation (Basingstoke), 2008-08, Vol.42 (S1), p.S66-S69

Soiffer, R J

2008

Volltextzugriff (PDF)

Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission

Blood, 2005-04, Vol.105 (7), p.2973-2978

2005

Volltextzugriff (PDF)

Immunohistopathological characterization and the impact of topical immunomodulatory therapy in oral chronic graft‐versus‐host disease: A pilot study

Oral diseases, 2018-05, Vol.24 (4), p.580-590

2018

Volltextzugriff (PDF)

Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age

Blood, 2005-02, Vol.105 (4), p.1810-1814

2005

Volltextzugriff (PDF)

Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis

Cancer, 2016-10, Vol.122 (19), p.3005-3014

2016

Volltextzugriff (PDF)

Renal failure associated with cancer and its treatment : An update

Journal of the American Society of Nephrology, 2005, Vol.16 (1), p.151-161

2005

Volltextzugriff (PDF)

A phase I/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2002-03, Vol.29 (5), p.373-377

2002

Volltextzugriff (PDF)

Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia

Blood, 2005-12, Vol.106 (13), p.4389-4396

2005

Volltextzugriff (PDF)

Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation

Blood, 2003-09, Vol.102 (5), p.1578-1582

2003

Volltextzugriff (PDF)

Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation

The Journal of experimental medicine, 2004-04, Vol.199 (8), p.1133-1142

2004

Volltextzugriff (PDF)

Pre-transplantation iron chelation in patients with MDS or acute leukemia and iron overload undergoing myeloablative allo-SCT

Bone marrow transplantation (Basingstoke), 2013-01, Vol.48 (1), p.146-147

2013

Volltextzugriff (PDF)

Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trial

Blood, 2004-09, Vol.104 (5), p.1559-1564

2004

Volltextzugriff (PDF)

Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors

Blood, 2004-01, Vol.103 (1), p.353-359

2004

Volltextzugriff (PDF)

Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study

Blood, 2003-10, Vol.102 (8), p.2768-2776

2003

Volltextzugriff (PDF)

Long-Term Follow-Up of Autologous Bone Marrow Transplantation in Patients With Relapsed Follicular Lymphoma

Blood, 1999-11, Vol.94 (10), p.3325-3333

1999

Volltextzugriff (PDF)

Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

Blood, 2004-08, Vol.104 (4), p.1224-1226

2004

Volltextzugriff (PDF)

Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation

Blood, 2003-09, Vol.102 (5), p.1601-1605

2003

Volltextzugriff (PDF)

Interleukin-1 blockade does not prevent acute graft-versus-host disease: results of a randomized, double-blind, placebo-controlled trial of interleukin-1 receptor antagonist in allogeneic bone marrow transplantation

Blood, 2002-11, Vol.100 (10), p.3479-3483

2002

Volltextzugriff (PDF)

Preinfusion variables predict the predominant unit in the setting of reduced-intensity double cord blood transplantation

Bone marrow transplantation (Basingstoke), 2008-03, Vol.41 (6), p.523-529

2008

Volltextzugriff (PDF)

Routine screening for psychosocial distress following hematopoietic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2005-01, Vol.35 (1), p.77-83

2005

Volltextzugriff (PDF)

1 – 25 von 116

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(108)
Mit Volltextzugriff
(105)

Publikationsform

Artikel
(116)

Sprache

Englisch
(116)

Erscheinungsjahr

n.n

Thema

Humans
(102)
Science & Technology
(101)
Life Sciences & Biomedicine
(97)
Female
(81)
Middle Aged
(80)
Adult
(78)
Male
(77)
Biological And Medical Sciences
(70)
Medical Sciences
(69)
Hematology
(61)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(50)
Transfusions. Complications. Transfusion Reactions. Cell And Gene Therapy
(50)
Bone Marrow, Stem Cells Transplantation. Graft Versus Host Reaction
(47)
Immunology
(38)
Oncology
(38)
Transplantation
(33)
Transplantation, Homologous
(33)
Treatment Outcome
(27)
Aged
(26)
Bone Marrow Transplantation
(21)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemia

Expansion, persistence, and efficacy of donor memory-like NK cells infused for posttransplant relapse

The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation

Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease

Biologic Activity of Cytotoxic T Lymphocyte-Associated Antigen 4 Antibody Blockade in Previously Vaccinated Metastatic Melanoma and Ovarian Carcinoma Patients

Immune modulation and chronic graft-versus-host disease

Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission

Immunohistopathological characterization and the impact of topical immunomodulatory therapy in oral chronic graft‐versus‐host disease: A pilot study

Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age

Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis

Renal failure associated with cancer and its treatment : An update

A phase I/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantation

Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia

Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation

Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation

Pre-transplantation iron chelation in patients with MDS or acute leukemia and iron overload undergoing myeloablative allo-SCT

Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trial

Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors

Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study

Long-Term Follow-Up of Autologous Bone Marrow Transplantation in Patients With Relapsed Follicular Lymphoma

Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation

Interleukin-1 blockade does not prevent acute graft-versus-host disease: results of a randomized, double-blind, placebo-controlled trial of interleukin-1 receptor antagonist in allogeneic bone marrow transplantation

Preinfusion variables predict the predominant unit in the setting of reduced-intensity double cord blood transplantation

Routine screening for psychosocial distress following hematopoietic stem cell transplantation

Suchergebnisse filtern